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Abstract
Brain damage caused by an acute injury depends on the initial severity of the injury and the time elapsed after
the injury. To determine whether these two variables activate common mechanisms, we compared the response
of the rat medial septum to insult with a graded series of concentrations of a-amino-3-hydroxy-5-methyl-4-
isoxazole propionic acid (AMPA) with the time-course effects of a low dose of AMPA. For this purpose we
conducted a dose-response study at concentrations of AMPA between 0.27 and 10.8 nmol to measure atrophy of
the septal area, losses of cholinergic and GABAergic neurons, astroglial and microglial reactions, and calcifi-
cation. Cholinergic neurons, whose loss paralleled the degree of septal atrophy produced by AMPA, are more
sensitive than GABAergic neurons to the injury produced by AMPA. At doses of AMPA above 2.7 nmol,
calcification and the degree of microglial reaction increased only in the GABAergic region of the septal area,
whereas atrophy and neuronal loss reached a plateau. We chose the 2.7-nmol dose of AMPA to determine how
these parameters were modified between 4 days and 6 months after injection. We found that atrophy and
neuronal loss increased progressively through the 6-month study period, whereas astrogliosis ceased to be
observed after 1 month, and calcium precipitates were never detected. We conclude that septal damage does not
increase with the intensity of an excitotoxic insult. Rather, it progresses continuously after the insult. Because
these two situations involve different mechanisms, short-term paradigms are inappropriate for interpreting the
pathogenic mechanisms responsible for long-term neurodegenerative processes.
Key words: adult brain injury; immunohistochemistry; in-vivo studies; neurodegenerative disorders; neuronal cell
death
Introduction
Acute brain injury is characterized by immediate,massive neuronal death and marked tissue injury oc-
curring through interdependent mechanisms such as gluta-
mate-mediated excitotoxicity, failure of cellular energetics,
acidosis, the generation of reactive oxygen species, and a
potent inflammatory response (Hazell, 2007; Baptiste and
Fehlings, 2006; van Landeghem et al., 2006; Arundine and
Tymianski, 2004; Sapolsky, 2001). Acute brain injury can also
activate a neurodegenerative process whose effects are time-
dependent and related to the initial severity of insult to the
central nervous system (CNS). Thus, for example, acute neu-
rological injury and chronic brain damage have been linked in
boxers, with a correlation between the prevalence of subdural
hematoma and dementia pugilistica (Miele et al., 2006;
Yoshiyama et al., 2005). The same occurs with the disruption
of the blood–brain barrier induced by a focus of epileptic
activity, which triggers delayed neurodegeneration and
functional cerebral impairment (Tomkins et al., 2007). Cere-
brovascular diseases and processes initiated by ischemia-
reperfusion may also be central in the pathogenesis of
Alzheimer’s disease (Zlokovic, 2005; Koistinaho and Koisti-
naho, 2005; Pluta, 2004). Neurodegenerative disorders are
characterized by distinct clinical features that result from a
discrete and ongoing neuronal loss, leading over periods of
years to specific structural alterations in the brain and various
forms of cerebral dysfunction (Zlokovic, 2005; Rao andWeiss,
2004). To investigate the complex relationship between a
graded acute brain insult and the pathogenic mechanisms
activated in chronic neurodegeneration in humans, it is nec-
essary to compare anatomical and cellular parameters in an
animalmodel related to a human disorder (Carvey et al., 2006;
Stefanova et al., 2005). Because they can exacerbate cerebral
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damage, including that caused by oxidative stress and excit-
atory amino acids (McEwen, 1992; Stein-Behrens et al., 1992),
glucocorticoids (GCs) may participate in the common brain
response to acute and chronic cerebral lesions. As an example
of this is that increased secretion of corticosterone, the pri-
mary GC in rodents, decreases hippocampal volume, the
length of apical dendrites, and the number of synapses in the
CA3 area of the hippocampus (Tata et al., 2006; Sousa et al.,
2000). However, this cannot be considered a universal re-
sponse because of unexpected proinflammatory effects evi-
dent in several brain regions (Sorrells and Sapolsky, 2007, for
a review).
Degeneration of neurons in the basal forebrain is respon-
sible for neurological deficits in both attention and specific
aspects of memory (Etienne et al., 1986; Arendt et al., 1985). To
simulate these impairments, animal modeling has focused on
acute in-vivo lesions of brain areas related to the hippocampus
in different experimental approaches to activate a neurode-
generative process (Ramonet et al., 2004a; Ginsberg et al.,
1999; Leutgeb and Mizumori, 1999). Thus, the acute micro-
injection of excitatory amino acids into the rat medial septum
and the diagonal band of Broca (DBB) induces neurodegen-
erative effects related to the hippocampus. The behavioral
deficits associated with cognitive processing (Leutgeb and
Mizumori, 1999; Brandner, 1998) reflect a hippocampal re-
duction in cholinergic activity (Zapata et al., 2000), and of
GABAergic and glutamatergic transmission (Rodrı´guez et al.,
2005; Waite et al., 1994).
The aim of the present study was to characterize the ana-
tomical and cellular effects of increasing acute excitotoxic
insults to the medial septum, and to determine whether
the ongoing process induced by these insults produces simi-
lar modifications over a prolonged period. To this end we
undertook a dose-response study of a-amino-3-hydroxy-5-
methyl-4-isoxazole propionic acid (AMPA) at concentrations
between 0.27 and 10.8 nmol, and a time-course study between
4 days and 6 months after AMPA-induced lesioning to de-
termine atrophy of the septal area, neuronal loss, astroglial
and microglial reactions, and brain calcification on a quanti-
tative basis. We evaluated the putative relationship between
these parameters through the use of correlation analysis and
three-dimensional (3-D) reconstruction. We also investigated




These experiments were performed with 2-month-old male
Sprague-Dawley rats (Charles River Laboratories, Barcelona,
Spain) weighing 250–300 g at the beginning of the study. The
animals were kept on a 12-hour light=12-hour dark cycle and
housed with free access to food and water. All animals were
treated according to the standards of the European Economic
Community (86=609=EEC) for animal handling and experi-
mentation. The procedures used in the study were approved
by the Ethics Committee of the Universitat de Barcelona,
under the supervision of the Generalitat de Catalunya; all
efforts were made to minimize animal suffering and to use
only the number of animals necessary to yield reliable scien-
tific data. AMPA, mouse monoclonal anti-glial fibrillary
acidic protein (GFAP) antibody, mouse monoclonal anti-
parvalbumin antibody, and the secondary antibodies used
here, and isolectin B4 and the immunohistochemical reagents
used were purchased from Sigma Chemical Co. (St. Louis,
MO). The mouse monoclonal anti-choline acetyltransferase
FIG. 1. Schematic drawing of coronal sections showing the four regions of the medial septum–diagonal band of Broca
complex where the histologic study was performed. The figures are redrawn from the atlas of Paxinos and Watson (1986),
and correspond to levels þ1.2mm, þ0.7mm, þ0.2mm, and 0.25mm relative to the bregma. The arrow shows the cannula
placement for the stereotaxic microinjections of AMPA, for which the cannula was inserted at an angle of 108 from the
vertical. Cell counts were made in the areas marked with the grids (ac, anterior commissure; cc, corpus callosum; DB,
diagonal band; LSD, lateral septal nucleus dorsal; LSV, lateral septal nucleus ventral; MS, medial septum; SHi, septo-
hippocampal nu). Nomenclature from the atlas of Paxinos and Watson (1986).
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(ChAT) antibody was from Chemicon Inc. (Temecula, CA),
and the rabbit monoclonal anti-GC receptor antibody (clone
M-20) was from Santa Cruz Biotechnology (Santa Cruz, CA).
Stereotaxic procedure
The rats were anesthetized with equithesin (a mixture of
chloral hydrate and sodium pentobarbitone; 0.3mL=100 g
body weight IP) and placed on a David Kopf Stereotaxic
frame (David Kopf Instruments, Inc., Tujunga, CA) with the
incisor bar set at 3.3mm. Single intraseptal injections were
made through a stainless steel cannula connected by Portex
tubing (Sims Medical, Inc., Keene, NH) to a Hamilton syringe
activated by an infusion pump (CMA=100; Carnegie Medicin,
Stockholm, Sweden). The cannula was inserted at an angle of
108 from vertical and positioned 0.7mm rostral to the bregma
and 1.1mm lateral and 5.0mm ventral from the dura (Paxinos
and Watson, 1986) (Fig. 1). The AMPA was dissolved in
50-mM phosphate-buffered saline (PBS; pH 7.4). Injections of
0.5 mL were made over a period of 5min each, and after
completion of the injection the cannula was left in place for an
additional 5min to allow for passive diffusion and to prevent
the spread of the excitotoxin up the cannula track upon re-
moval of the cannula. The cannula was then slowly retracted.
Dose-response study
Thirty-two animals were divided into eight groups (n¼ 4
per group). Each rat received a single injection into the medial
septum of either PBS, or AMPA at 0.27 nmol, 1.4 nmol,
2.7 nmol, 5.4 nmol, 8.1 nmol, or 10.8 nmol. The remaining
untreated rats (n¼ 4) were used as controls. These doses of
AMPA were chosen according to results of previous studies
(Andre´s et al., 2003; Petegnief et al., 1999).
At 2 months after the injection of PBS or AMPA, the rats
were anesthetized and perfused transcardially with ice-cold
fixative consisting of 0.4% (w=v) picric acid and 4% (w=v)
paraformaldehyde in 0.1M PBS (pH 7.4). The animals’ brains
were rapidly removed, post-fixed for 2 h, transferred to 15%
(w=v) sucrose in PBS, and stored at 48C for 3 days. The brains
were then frozen with dry ice and stored at 808C until use.
Time-course study
To perform the time-course study of the effects of excitatory
injury to the medial septum, we selected the dose of 2.7 nmol
AMPA from the dose-response study. We divided 42 rats into
two groups, which received either a single injection of PBS
(n¼ 20) or AMPA (n¼ 22). The rats were anesthetized and
perfused transcardially as previously described at 4 days, 15
days, 1 month, 2 months, or 6 months after injection. At each
time point, 4 sham-treated and 4 AMPA-treated animals were
killed, except for the final, 6-month time point, at which 4
sham and 6 AMPA-treated rats were used. The animals’
brains were rapidly removed, cryoprotected, frozen, and
stored at 808C until used.
Histology and immunohistochemistry
Serial sections of 12mm eachwere obtained from each brain
along the entire rostrocaudal extension of the medial septum-
DBB complex. Histological studies were done at four levels of
the medial septum to allow full coverage of this area of the
brain (the levelsþ 1.2,þ 0.7,þ 0.2, and 0.25mm relative to
the bregma) (Fig. 1). Some sections were processed for Nissl
standard staining with cresyl violet. Calcium deposits were
visualized by means of staining with alizarin red and coun-
terstaining with fast green (Bernal et al., 2000; Robledo et al.,
1999). Histochemistry for isolectin B4 was done to identify the
microglial reaction as previously described (Colton et al.,
1992); some of these sections were counterstained with aliz-
arin red.
Immunohistochemistry was done with the avidin-biotin-
peroxidase method as previously described (Rodrı´guez et al.,
2004; Ramonet et al., 2004b). Sections were incubated sepa-
rately at 48C with mouse monoclonal anti-GFAP diluted at
1:600 (v=v) in normal goat serum (NGS; 1:100 v=v in 0.01M
PBS; pH 7.4), mouse monoclonal anti-parvalbumin diluted at
1:600 (v=v) in NGS, mouse monoclonal anti-ChAT diluted at
1:400 (v=v) in NGS, or rabbit monoclonal anti-GC receptor
diluted at 1:750 (v=v) in NGS. After incubation with the ap-
propriate secondary antibodies and ExtrAvidin (Sigma-
Aldrich, Inc.), the sections were developed in 0.05M Tris
containing 0.03% (w=v) diaminobenzidine and 0.006% (v=v)
H2O2. Some sections were counterstained with alizarin red.
The total septal area was measured at the four studied
levels of the medial septum on Nissl-stained sections, using
a computer-assisted image analysis system (OPTIMAS; Bio-
Scan Inc., Washington, DC). The septal area was defined ac-
cording to Mahy and associates (1995). The laterally adjacent
area of the caudate putamen was measured in the same sec-
tions to estimate the effects of histological procedures on tis-
sue size, and to correct for variability in individual brain size
and tissue shrinkage. Calcified areas were quantified on
alizarin red–stained sections as previously described (Pe-
tegnief et al., 1999; Robledo et al., 1999). For each sample, color
digital images of two different non-counterstained sections
were taken with a light microscope, and the total area stained
in red was quantified using the OPTIMAS image analysis
system. GC receptor density was analyzed densitometrically
on black-and-white microscopic images made from GC-
receptor immunostained sections (Hwang et al., 2005), also
using the OPTIMAS image analysis system. Cell counts were
made on parvalbumin and ChAT-immunostained sections.
The method of Floderus (Floderus, 1944) was used to correct
for the thickness of sections. Because of the difficulty in
identifying the border between the medial septum and the
DBB, these two areas were separated by drawing a theoretical
line at the level of the anterior commissure (Mahy et al., 1995).
The area of astroglial reaction was measured on GFAP-
immunostained sections.
Three-dimensional reconstruction
In order to quantify and analyze the precise location of
medial septal atrophy and calciumdeposit distributionwithin
the medial septum-DBB complex, 3-D reconstruction was
done as previously described (Prats-Galino et al., 1999). In
brief, using an Olympus BH2 microscope (Olympus, Inc.,
Tokyo, Japan) with an attached drawing tube, we examined
all four of the serial sections of the medial septum and out-
lined them on paper at a final magnification of 22. The
computer analysis consisted of three steps: (1) digitization of
the positions of the calcium deposits and tissue-structure
contours was done with a digitizing scanner connected to
an image analysis system (Adobe Photoshop 4.0; Adobe
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Systems, Inc., San Jose, CA); (2) 3-D surface reconstruction of
the serial sections was done by triangulation with software
specially developed for this purpose (Prats-Galino et al.,
1988); and (3) generation of a shaded 3-D model from the
resulting triangulated image by using 3D Studio Max 1.2
software (Kinetix Autodesk, Inc., San Rafael, CA). The origi-
nal data files were transformed into virtual reality modeling
language format and converted with the Crossroads File
Format Converter (Crossroads Systems, Inc., Austin, TX) into
Autocad drawing exchange format (DXF) (Autodesk, Inc.,
San Rafael, CA) to be used by 3D Studio Max.
Statistical analysis
In the time-course study, no age-related change in any of
the parameters was observed in control 2- and 8-month-old
rats. This was also the case for all of the studies of the sham-
treated rats. Because of this, the values recorded for these
animals were pooled into a single group and designated the
control values. For each parameter, kurtosis and skewness
moments were calculated to test for normal distribution of the
data. One-way analysis of variance (ANOVA) followed by the
post-hoc least significant difference test was used to compare
differences between groups. When normality was not
reached, the non-parametric Kruskal-Wallis (KW) test fol-
lowed by the Mann-Whitney U test was used to compare
values for all groups. All data are given as mean SEM.
Neuronal loss is expressed as a percentage of the control
value. Linear regressions were performed to compare the
evolution of different parameters. In all cases a value of
p< 0.05 was considered significant. Analyses were done with
Statgraphics computer software (STSC Inc., Rockville, MD).
Results
Dose-response study
Twomonths after AMPA injection, a reduction of the entire
septal area was found at the four studied levels at all doses of
AMPA except for the 0.27-nmol dose (Fig. 2). The progressive
reduction in area reached a plateau at 2.7 nmol AMPA, with a
value that was 35–40% of the control value. The Kruskal-
Wallis test values for each studied level of the medial sep-
tum were: KW¼ 22.4, p¼ 0.0010; KW¼ 22.2, p¼ 0.0012;
FIG. 2. Effect on septal area size of AMPA-induced lesion in the medial septum. Photomicrographs illustrate the evolution
of septal atrophy and show cresyl violet–stained septal areas at the injection level in controls (a), at 15 days (b), and at
6 months (c) after injection of 2.7 nmol of AMPA. Graphs show the quantification of the septal area for all doses of AMPA (d),
and for the 6-month course of the study (e) at the four studied levels of the medial septum. Note the different curve shapes,
which are quickly saturable for the dose-response study, and far more progressive for the time-course study. For all situations
n¼ 4 for both the control and AMPA-treated groups, except for the 6-month time point, at which n¼ 4 for the control group
and n¼ 6 for the AMPA-treated group (*p< 0.05; **p< 0.01; ***p< 0.001 versus controls; #p< 0.05 versus 2-month lesion on
Mann-Whitney U test; scale bar¼ 250mm).
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KW¼ 17.7, p¼ 0.0069; and KW¼ 19.7, p¼ 0.0031, for þ1.2,
þ0.7,þ0.2, and0.25mm relative to the bregma, respectively.
When adjacent striatal areas were measured, no differences
were found between any of the groups of animals at any of the
studied levels (data not shown).
Beginning at 1.4 nmol of AMPA, all four studied septal
levels showed a 70–80% loss of ChAT-immunopositive neu-
rons (Fig. 3) (KW¼ 23.41, p¼ 0.0007; KW¼ 23.06, p¼ 0.0008;
KW¼ 25.84, p¼ 0.0002; and KW¼ 20.80, p¼ 0.002, for þ1.2,
þ0.7, þ0.2, and 0.25mm relative to the bregma, respec-
tively). ChAT-immunopositive neurons of the DBB were de-
creased only at the level of AMPA injection, owing to a slight
loss of neurons in the vertical limb. When the size of areas of
ChAT-immunopositive neurons in the medial septum was
measured directly on photomicrographs, no difference was
found between controls (mean diameter: 18 2 mm; n¼ 40)
and lesioned animals (mean diameter: 17 2 mm; n¼ 60).
GABAergic neurons were also sensitive to AMPA. At
the injection level, the percentage of parvalbumin-
immunopositive neurons was decreased by 55–80% with in-
creasing doses of AMPA (KW¼ 24.13, p¼ 0.0005; KW¼ 23.62,
p¼ 0.0006; KW¼ 24.18, p¼ 0.0005; and KW¼ 24.13,
p¼ 0.0005, for þ1.2, þ0.7, þ0.2, and 0.25mm relative to the
bregma, respectively). The most severe GABAergic neuronal
loss was reached at a dose of 5.4 nmol AMPA. Direct mea-
surement of neuronal body size showed no difference be-
tween controls (mean diameter: 20 4mm; n¼ 40) and
lesioned animals (mean diameter: 19 3mm; n¼ 30).
FIG. 3. Characterization of AMPA-induced neuronal loss in the medial septum. Photomicrographs illustrate the neuronal
loss at the level of injection, and show ChAT-immunostained sections of control rats (a) and AMPA-lesioned rats at 15 days
(b) and 6 months (c) after lesioning, and parvalbumin-immunopositive neurons of control rats (d) and lesioned rats at
2 months (e) after injection of 2.7 nmol of AMPA. Graphs show the quantification of neuronal loss for all AMPA doses (f) and
at 6 months (g) of the study at the four studied levels of the medial septum (ChAT, ChAT-immunostained neurons; parv,
parvalbumin-immunostained neurons). Note the different sensitivity to AMPA between ChAT-immunopositive and Parv-
immunopositive neurons. Note also the different curve shapes, showing that ChAT-immunopositive neurons were rapidly
saturable in the dose-response study, and the more progressive curve for the time-course study. For all situations, n¼ 4 for
both the control and AMPA-treated groups, except for the 6-month time point, at which n¼ 4 for the control group and n¼ 6
for the AMPA-treated group (*p< 0.05; **p< 0.01 versus controls; $p< 0.05 versus 2.7 nmol AMPA by Mann-Whitney U test;
scale bar¼ 75mm).
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With the exception of the most rostral level of the medial
septum (þ1.2mm relative to the bregma), calcium deposits
were found only at doses of AMPA higher than 2.7 nmol
(KW¼ 16.7, p¼ 0.0021 atþ 0.7mm relative to the bregma;
KW¼ 17.2, p¼ 0.0042 atþ 0.2mm relative to the bregma; and
KW¼ 10.9, p¼ 0.026 at0.25mm relative to the bregma). The
2.7-nmol dose of AMPA induced calcification in the medial
septum in only half of the animals. Although showing a ten-
dency to increase with increasing AMPA dose, this calcifica-
tion process was not dose-dependent (Fig. 4). Localized
within the GABAergic neuronal area, these precipitates ap-
peared mainly in the center of the medial septum, and were
less common in the ventral region of the DBB. The precipitates
showed no relationship to blood vessels or to the injection-
needle scar.
No astroglial reaction was detected by GFAP immuno-
histochemistry in the septal area. Only the needle scar showed
a slight increase in astroglial immunostaining. At all doses of
AMPA above 2.7 nmol, the astrocytes showed a different
morphology, characterized by smaller size and fewer cellular
processes in the lesioned area than in the lateral septum or the
medial septum of control rats (Fig. 5). Histochemistry for
isolectin B4-stained activated microglia were positive only in
AMPA-treated animals that showed calcium deposits. Ali-
zarin red counterstaining showed reactive microcytes asso-
ciated with calcium deposits in the center of the medial
septum-DBB complex.
Time-course study
The 2.7-nmol dose of AMPA was selected for the dose-
response study because of its efficacy in producing an inter-
mediate state of septal lesioning. The progressive decrease in
septal area at the four studied levels (KW¼ 21.9, p¼ 0.0005;
KW¼ 23.3, p¼ 0.0003; KW¼ 21.4, p¼ 0.0007; and KW¼ 22.3,
p¼ 0.0005, for þ 1.2, þ0.7, þ0.2, and 0.25mm relative to the
bregma, respectively) reached significance at 2 months after
AMPA injection (at 35% of the control value), and was still
increasing at 6 months after injection (Fig. 2). When adjacent
striatal areas were measured, no difference was again found
between any groups of animals at any of the studied levels
(data not shown).
At 4 days after injection of the 2.7-nmol dose of AMPA, a
40% loss of ChAT-immunoreactive neurons was observed
in the medial septum (KW¼ 21.6, p¼ 0.0006; KW¼ 17.7,
p¼ 0.0014; KW¼ 22.5, p¼ 0.0004; and KW¼ 21.7, p¼ 0.0008,
FIG. 4. Analysis of calcification induced by AMPA in the medial septum. Photomicrographs of (a) parvalbumin-
immunostained neurons (arrow), (b) GFAP-immunostained astrocytes (arrow), and (c) isolectin B4–stained microglia in
sections counterstained with alizarin red. Note the calcium deposits localized at sites where GABAergic neurons are more
abundant, and the close relationship between calcium deposits and reactive microcytes (arrows in c). The dose of AMPA was
8.1 nmol. (d) Graphs showing the quantification of calcium deposits at the three septal levels that exhibited calcification. In all
cases n¼ 4 for both the control and AMPA-treated groups (*p< 0.05; **p< 0.01 versus controls on Mann-Whitney U test; scale
bar¼ 40mm). (Color image is available online at www.liebertpub.com=jon)
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FIG. 5. Effects of AMPA on septal astrocytes and GC receptor distribution. Photomicrographs show astrocyte morphology
(a–c) and GC receptor distribution (d–f) in the medial septa of control rats and rats treated with 2.7 nmol AMPA at 2 months
after lesioning. GFAP immunohistochemistry in medial septum of control rats (a), lateral septum of lesioned rats (b), and
medial septum of lesioned rats (c). Note the loss of processes and cellular shrinkage in c as compared with a and b. GC
immunohistochemistry in control rats (d) and lesioned rats (e). There is evidence of increased labeling in surviving neurons
(arrowheads) and astrocytes (arrows). Astrocytes in the lesioned area of the medial septum that lacked surviving neurons (f )
also showed increased GC immunoreactivity. (g) Graph of the quantification of GC immunoreactivity in cells from the septal
area at the level of injection of AMPA. In all cases n¼ 4 for both the control and AMPA-treated groups (LS, lateral septum;
MS, medial septum; OD, optical density; *p< 0.05 versus controls by Mann-Whitney U test; scale bar¼ 30 mm).
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for þ1.2, þ0.7, þ0.2, and 0.25mm relative to the bregma,
respectively), and increased progressively to reach 85% after
6 months (Fig. 3). A similar progression was also seen in the
vertical limb of the DBB. Parvalbumin-immunostained neu-
rons were reduced in number only at the three anterior sep-
tal levels (KW¼ 15.5, p¼ 0.0082; KW¼ 18.3, p¼ 0.0025;
KW¼ 21.1, p¼ 0.0008, forþ1.2,þ0.7, andþ0.2mm relative to
the bregma, respectively), with an insignificant reduction at
0.25mm to the bregma. At 4 days the reduction reached
35%, but thereafter progressed only for 2 months (Fig. 3).
ChAT- or parvalbumin-immunostained neurons of lesioned
rats were of the same size as those of the controls.
No calciumdeposits were found in the septal area of any rat
at any time. At 4 days after the injection of PBS, im-
munostaining for GFAP showed a small area of astrogliosis
(0.27 0.02 mm2) localized at the injection site. At this same
4-day time point, AMPA injection had induced marked as-
trogliosis in the lateral and medial septum and in the vertical
limb of the DBB throughout the rostrocaudal extension of the
latter structure (1.41 0.08 mm2 at the injection level). This
astrogliosis, although still present at 15 days after AMPA in-
jection, was reduced in intensity and extent (0.81 0.06 mm2 at
the injection level), and was no longer detectable at 1 month
after lesioning. At longer intervals, astrocytes in the lesioned
area of the medial septum showed an abnormal morphology,
with reduced size and fewer cellular processes than control
cells (Fig. 5). In no animal did staining for isolectin B4 show a
microglial reaction in the septal area.
Glucocorticoid receptors
Immunohistochemistry for GC receptors showed a wide-
spread distribution of these receptors in the medial septum-
DBB complex, lateral septal nuclei, and adjacent areas of
control animals. Staining specific for GC receptors was pres-
ent in the cytoplasmandnuclei of neurons andglial cells (Fig. 5),
but was always stronger in the cells’ nuclei. At 2 months after
the injection of 2.7 nmol of AMPA, increased GC receptor im-
munoreactivity in the lesioned area of the medial septum
(KW¼ 13.187; p¼ 0.021) was observed, mainly in the nuclei of
astrocytes (a 36% increase), and surviving neurons (a 24% in-
crease). No increasewas observed in theDBB, lateral septum, or
caudate putamen.
Correlations and 3-D reconstruction
Statistical correlation studies done to estimate the rela-
tionship between septal atrophy, neuronal loss, and calcifi-
cation gave similar results at all four studied levels of the
medial septum (Table 1). In the dose-response and time-
course studies, the correlation coefficient for the number
of ChAT-immunostained neurons with neuronal atrophy
was greater than that for the number of parvalbumin-
immunostained neurons and atrophy. The greatest correla-
tion was found between cholinergic and GABAergic neuronal
loss. In the dose-response study, only the calcified area
showed a positive correlation with GABAergic neuronal loss.
3-D reconstruction clearly showed the contribution of
lateral septal nuclei to atrophy of the septal area (Fig. 6) at
2 months after injection of the 2.7-nmol dose of AMPA, and
also showed the increase in this atrophy with both increasing
AMPA concentration and time after lesioning. No specific
atrophy was detected in the DBB. In this analysis, increasing
time after lesioning showed a greater effect on septal atrophy
than did AMPA concentration. Neuronal loss in the medial
septum-DBB complex, which was restricted to the medial
septum and a small part of the vertical limb of the DBB, in-
creased with AMPA concentration, but not with time after
lesioning. AMPA-induced calcification was observed at the
center of the medial septum and ventral region of the DBB,
which are rich in GABAergic neurons. The calcification was
limited to the lesioned area and located caudally to the in-
jection site.
Discussion
This study demonstrates that acute AMPA-induced le-
sioning of the medial septum triggers a long-term neurode-
generative process characterized by progressive septal
atrophy and a loss of cholinergic and GABAergic neurons, as
Table 1. Linear Regression Analysis of Medial Septal Lesion atþ 0.2mm to the Bregma
Septal area ChAT counts Parvalbumin counts
Dose-response
ChAT counts r2¼ 0.61, p¼ 0.0001
Parvalbumin counts r2¼ 0.52, p¼ 0.0001 r2¼ 0.82, p< 0.00001
Calcified area r2¼ 0.29, p¼ 0.0017 r2¼ 0.38, p< 0.0002 r2¼ 0.46, p< 0.001
Time-course
ChAT counts r2¼ 0.45, p¼ 0.0001
Parvalbumin counts r2¼ 0.43, p¼ 0.0001 r2¼ 0.57, p< 0.00001
ChAT, choline acetyltransferase.
FIG. 6. 3-D reconstructions of the rat medial septum-DBB complex and adjacent structures. Illustrative representation of a
3-D reconstruction of the septal zone (a), medial septum (b), and lesioned medial septum (c) of one control and three lesioned
rats at different post-lesion time-points and AMPA doses. Each structure has a different color: lateral ventricles are shown in
red, medial septum in blue, anterior commissure in green, lesioned medial septum in yellow, and calcification in pink. The
observer is at the rostral (a) and rostrolateral (b and c) sides of the reconstruction. To allow for visualization of lesions and
calcification inside the medial septum, structures in b and c are presented as triangular facets (r, right; l, left; scale
bar¼ 1mm). (Color image is available online at www.liebertpub.com=jon)
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well as increased GC receptor density in the absence of a
astroglial or microglial reaction. The septal atrophy, cholin-
ergic andGABAergic neuronal loss, and calcium precipitation
observed in the dose-response study done with AMPA imply
the activation of a mechanism that differs from that in the
ongoing neurodegenerative process.
Compared to the acute injury induced by AMPA, whose
effects reached a plateau at about 5.4 nmol of AMPA, the long-
term evolution of the lesion induced by this neurotoxin was
characterized by increasing and continuing atrophy and
cholinergic neuronal loss in the absence of astrogliosis
throughout the 6-month duration of our study. Previous
studies done with quisqualic or ibotenic acid under similar
conditions, found a similarly severe atrophy of the medial
septum after a 1-year period (Ramani et al., 2006; Yoshiyama
et al., 2005; Leutgeb and Mizumori, 1999; Mahy et al., 1995).
Notwithstanding the heterogeneity in anatomic organization
and neuronal composition of the medial septum (Kiss et al.,
1990), our data showed a similar atrophy throughout its entire
structure. 3-D reconstruction and the astrogliosis observed
within the first 15 days after lesioning indicate an initial injury
to the lateral nuclei from the microinjection of AMPA into the
medial septum. This is no surprise given the high glutamate
receptor density of the lateral septal nuclei (Le Jeune et al.,
1996; Stewart and Vanderwolf, 1987). Although the progres-
sive loss of cholinergic neurons observed in our study corre-
lates with atrophy, it cannot be associated with neuronal
shrinkage, since no reduction in the size of cholinergic and
GABAergic neuronal soma was found. However, other fac-
tors, such as lesioning of the lateral septum, absence of an
astroglial reaction, and reduction in numbers of dendritic
processes, may all contribute to a reduction in septal area.
Prolonged exposure to high concentrations of GCs may ex-
acerbate the adverse consequences of chronic brain insults
(Sorrells and Sapolsky, 2007). Thus for example, shrinkage of
astrocytes and a reduction in the numbers of their processes,
as found at 2 months after injection of AMPA in our study,
may result from a reduced uptake of glucose consequent to an
increased density of GC receptors and loss of synaptic con-
tacts (Tata et al., 2006).
Calcification develops in most areas of the rat brain fol-
lowing the in-vivo microinjection of several excitotoxins, and
also develops in humans after acute brain injury (Ramonet
et al., 2006; Casanova and Araque, 2003; Rodrı´guez et al.,
2001; Herrmann et al., 1998; Ansari et al., 1990). The pattern of
calcification in each area of the brain reflects its sensitivity to
injury (Lammie et al., 2005; Rodrı´guez et al., 2004; Bernal et al.,
2000; Mahy et al., 1995). The medial septum, which is more
resistant to AMPA-induced excitotoxicity than are the hippo-
campus, globus pallidus, and cerebral cortex (Rodrı´guez et al.,
2000), developed calcification only at the highest concentra-
tions of AMPA, but not over a long time interval after le-
sioning. This is consistent with calcification in the human
brain induced by perinatal ischemia and hypoxia, which has
been found to be directly related to the intensity of an insult,
but not to the time after its occurrence (Rodrı´guez et al., 2001;
Ansari et al., 1990).
Among the factors responsible for the resistance of the
medial septum to calcification and excitotoxicity are gluta-
mate receptors, calcium-binding proteins, a low level of en-
ergy availability, astrocytes, and GABAergic neurons, all of
which are directly involved in the brain-calcification process
(Ramonet et al., 2006; Rodrı´guez et al., 2004). A reason for this
is that the medial septum, compared with other areas such as
the hippocampus, has fewer AMPA binding sites with a
similar pharmacologic specificity (Le Jeune et al., 1996; Nicolle
et al., 1996), and the same is true for metabotropic glutamate
receptors of type I (Hollmann and Heinemann, 1994). The
parvalbumin expressed in GABAergic neurons rapidly re-
tains large amounts of free calcium (Rodrı´guez et al., 2004),
and thus helps to reduce calcium mobility and calcification.
This facilitates the marked resistance to injury of astrocytes,
reduced formation of lactate as an energy source, and absence
of microgliosis observed in the medial septum (Rodrı´guez
et al., 2004; Ramonet et al., 2004a; Ramonet et al., 2002). The
lack of neuronal calcification seen at 6 months after injection
of the 2.7-nmol dose of AMPA qualifies calcification as an
acute process. A microglial reaction, such as that observed in
this study, is a direct phagocytic and inflammatory response
to the formation of calcium deposits (Rodrı´guez et al., 2004;
Saura et al., 1995).
In contrast to the dose-response data for the injection of
AMPA that were obtained in our study, septal atrophy and
cholinergic neuronal loss progressed with time without as-
sociated astrogliosis or microgliosis. From 15 days on, the
effects of acute injury are counteracted (Sapolsky, 2001), but
this is not true for the underlying long-term process that leads
to tissue atrophy and cholinergic neuronal loss, as is also
observed in Alzheimer’s disease (Mamelak, 2007). Astrocyte
dysfunction is a key factor in the pathogenesis of human
neurologic disorders (Seifert et al., 2006), and in the cognitive
impairment of aged rats (Andre´s et al., 2000). In the case of the
chronic lesion, the combined atrophy of astrocytes and lack of
astrogliosis suggest a maladaptive response that may be a
cause of the ongoing pathologic process.
In sum, the AMPA-induced septal neurodegeneration ob-
served in our study involves specific mechanisms that protect
against GABAergic neuronal loss and calcification. This im-
plies astroglial dysfunction and probably participation by GC
signaling pathways in this neurodegeneration. These features,
absent with increasing AMPA concentration, would then be
parameters of chronic damage underlying hippocampal
dysfunction. Accordingly, our data showing differences be-
tween the acute effects of a graded excitotoxic lesion and its
effects over an extended course of time may help explain the
differences observed in rat behavior with acute as opposed to
chronic injury to the medial septum. Excitotoxic lesioning of
the medial septum reproduces the memory impairments ob-
served with aging in the rat (Leutgeb and Mizumori, 1999;
Gallagher et al., 1993). In this setting, the best results are not
obtained after an intense cholinergic injury to the medial
septum (Waite et al., 1994), but by modifying the relative
strengths of intrahippocampal inhibitory and excitatory con-
nections (Leutgeb and Mizumori, 1999).
Conclusion
In conclusion, the study described here demonstrates that
the effects that we observed in the medial septum in response
to graded excitotoxic insults reached a plateau with time. In
contrast, the long-term neurodegenerative process triggered
by these insults develops with specific pathogenic mecha-
nisms that increase septal damage with the passage of time.
These differences in sensitivity of the medial septum to acute
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and chronic damage underlie the involvement of different
mechanisms activated by such damage. This indicates that
paradigms for the short-term effects of injury to the brain are
inappropriate for elucidating the pathogenic mechanisms of
long-term neurodegenerative processes.
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